News
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): Kaufen
First Berlin Equity Research publishes research update on Knaus Tabbert AG, confirming BUY rating with revised target price of €29. Company outlines 2024 results and 2025 guidance, signaling positive outlook after strategic realignment -
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Rentschler Biopharma appoints Robert Panting as VP Global Client Program Management and Strategy
Rentschler Biopharma appoints Robert Panting as VP Global Client Program Management and Strategy. Dr. Panting to lead global Strategy initiatives and CPM functions in biopharmaceutical industry